Global Injectable Drug Delivery Market is Growing at a Significant Rate in the Forecast to 2024
The Global Injectable Drug Delivery Market is expected to reach USD 789.7 billion by 2024 from USD 330.6 billion in 2016, at a CAGR of 11.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of
(EMAILWIRE.COM, September 25, 2018 ) The Global Injectable Drug Delivery Market is expected to reach USD 789.7 billion by 2024 from USD 330.6 billion in 2016, at a CAGR of 11.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Get Free sample report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-injectable-drug-delivery-market
Market Segmentation: Global Injectable Drug Delivery Market
By Type (Devices {Conventional Injection, Self-Injection}, Formulations {Conventional Drug Delivery, Noble Drug Delivery, Long Acting Injection Formulations}, Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology), Usage Pattern (Curative Care, Immunizations), Mode of Administration (Skin, Circulatory, Organs, Central Nervous System), End User (Hospitals & Clinics, Home Care Settings, Research Laboratories, Pharma& Biotech Companies), Geography (North America, Europe, Asia-Pacific, South America, Middle East Africa)
Market Drivers: Global Injectable Drug Delivery Market
Some of the major factors driving the market for injectable drug delivery market, such as increasing use of biologics, rising prevalence of chronic diseases, increasing occurrence of needle-stick injuries, and the benefits of injections (convenience, ease of use, and reduced pain). These factors increase the demand for devices such as safety syringes, prefilled syringes, and auto-disabled syringes. Increasing prevalence of chronic diseases, rising demand for self-injection devices, growth of the biologics, and technological advancements are the major factors driving the growth of the injectable drug delivery market.
RISING CASES OF CHRONIC DISEASES
In recent years, the prevalence of chronic diseases (such as cancer, diabetes, hormonal disorder, and many others) across the globe has increased considerably over a period of time. The rapidly increasing aging population and the subsequent rise in chronic conditions are major factors driving the demand forself-injection devices and cost of healthcare.
RISING DEMAND OF SELF-INJECTION DEVICES
Self-injection devices are a combination of automatic injection systems with audio-visual guides for surgeries; this includes safety syringes and hidden needles, among others. It has also emerged as one of the fastest growing areas for unit dose medication in order to minimize drug waste and increase product lifespan.
Inquire before buying @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-injectable-drug-delivery-market
GROWTH OF BIOLOGICS MARKET
The biologics market is considered to be the fastest-growing sector of the pharmaceutical industry. Biologics are large molecules that require to be administered by injections given their size and profile. Biologics are medicines made from living cells through highly complex manufacturing processes used to prevent, treat, diagnose, or cure a variety of serious and chronic illnesses including cancer, chronic kidney disease, autoimmune disorders, and infectious diseases.
TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS IN DRUG DELIVERY MARKET
The injectable drug delivery technology market is expected to show significant growth in the coming years, due to various technological advancements and new product launches in order to improve the convenience and ease of administration of parenteral therapeutics.
Major Players: Global Injectable Drug Delivery Market
Some of the major players operating in this market are :
• Baxter International, Inc.
• Becton Dickinson and Company
• Gerresheimer AG, Pfizer, Inc.
• Schott AG, Alkermes Plc.
• Eli Lilly and Company
• Sandoz
• Terumo Corporation
• Teva Pharmaceuticals Industries Ltd.
• Bespak, Antares Pharma
• Elcam Medical
• Haselmeier
• Mylan N.V.
• Novo Nordisk
• Owen Mumford Ltd
• Sanofi
• West Pharmaceutical Services, Inc
• Ypsomed Holding AG.
Access Full Report : https://databridgemarketresearch.com/reports/global-injectable-drug-delivery-market/
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
Get Free sample report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-injectable-drug-delivery-market
Market Segmentation: Global Injectable Drug Delivery Market
By Type (Devices {Conventional Injection, Self-Injection}, Formulations {Conventional Drug Delivery, Noble Drug Delivery, Long Acting Injection Formulations}, Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology), Usage Pattern (Curative Care, Immunizations), Mode of Administration (Skin, Circulatory, Organs, Central Nervous System), End User (Hospitals & Clinics, Home Care Settings, Research Laboratories, Pharma& Biotech Companies), Geography (North America, Europe, Asia-Pacific, South America, Middle East Africa)
Market Drivers: Global Injectable Drug Delivery Market
Some of the major factors driving the market for injectable drug delivery market, such as increasing use of biologics, rising prevalence of chronic diseases, increasing occurrence of needle-stick injuries, and the benefits of injections (convenience, ease of use, and reduced pain). These factors increase the demand for devices such as safety syringes, prefilled syringes, and auto-disabled syringes. Increasing prevalence of chronic diseases, rising demand for self-injection devices, growth of the biologics, and technological advancements are the major factors driving the growth of the injectable drug delivery market.
RISING CASES OF CHRONIC DISEASES
In recent years, the prevalence of chronic diseases (such as cancer, diabetes, hormonal disorder, and many others) across the globe has increased considerably over a period of time. The rapidly increasing aging population and the subsequent rise in chronic conditions are major factors driving the demand forself-injection devices and cost of healthcare.
RISING DEMAND OF SELF-INJECTION DEVICES
Self-injection devices are a combination of automatic injection systems with audio-visual guides for surgeries; this includes safety syringes and hidden needles, among others. It has also emerged as one of the fastest growing areas for unit dose medication in order to minimize drug waste and increase product lifespan.
Inquire before buying @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-injectable-drug-delivery-market
GROWTH OF BIOLOGICS MARKET
The biologics market is considered to be the fastest-growing sector of the pharmaceutical industry. Biologics are large molecules that require to be administered by injections given their size and profile. Biologics are medicines made from living cells through highly complex manufacturing processes used to prevent, treat, diagnose, or cure a variety of serious and chronic illnesses including cancer, chronic kidney disease, autoimmune disorders, and infectious diseases.
TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS IN DRUG DELIVERY MARKET
The injectable drug delivery technology market is expected to show significant growth in the coming years, due to various technological advancements and new product launches in order to improve the convenience and ease of administration of parenteral therapeutics.
Major Players: Global Injectable Drug Delivery Market
Some of the major players operating in this market are :
• Baxter International, Inc.
• Becton Dickinson and Company
• Gerresheimer AG, Pfizer, Inc.
• Schott AG, Alkermes Plc.
• Eli Lilly and Company
• Sandoz
• Terumo Corporation
• Teva Pharmaceuticals Industries Ltd.
• Bespak, Antares Pharma
• Elcam Medical
• Haselmeier
• Mylan N.V.
• Novo Nordisk
• Owen Mumford Ltd
• Sanofi
• West Pharmaceutical Services, Inc
• Ypsomed Holding AG.
Access Full Report : https://databridgemarketresearch.com/reports/global-injectable-drug-delivery-market/
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
Contact Information:
Data Bridge Market Research
Data Bridge Market Research
Tel: +1-888-387-2818
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Data Bridge Market Research
Data Bridge Market Research
Tel: +1-888-387-2818
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results